Ken Fisher Ptc Therapeutics, Inc. Transaction History

Fisher Asset Management, LLC

$243 Billion
Q3 2024

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 06, 2024	SELL	$18.07 - $29.37 $114,907 - $186,763	-6,359 Reduced 6.23%	95,778 $2.64 Million
Q3 2023 Nov 13, 2023	SELL	$22.41 - $41.99 $1.15 Million - $2.15 Million	-51,165 Reduced 33.38%	102,137 $2.29 Million
Q2 2023 Dec 12, 2023	BUY	$40.4 - $59.1 $2.07 Million - $3.02 Million	51,165 Added 50.09%	153,302 $6.23 Million
Q2 2023 Aug 08, 2023	SELL	$40.4 - $59.1 $626,523 - $916,522	-15,508 Reduced 9.19%	153,302 $6.23 Million
Q1 2023 Dec 12, 2023	BUY	$38.16 - $48.86 $2.1 Million - $2.69 Million	54,983 Added 53.83%	157,120 $7.61 Million
Q1 2023 May 01, 2023	SELL	$38.16 - $48.86 $1.22 Million - $1.57 Million	-32,067 Reduced 15.96%	168,810 $8.18 Million
Q4 2022 Feb 03, 2023	SELL	$33.53 - $54.79 $117,723 - $192,367	-3,511 Reduced 1.72%	200,877 $7.67 Million
Q3 2022 Nov 08, 2022	SELL	$41.85 - $53.85 $958,741 - $1.23 Million	-22,909 Reduced 10.08%	204,388 $10.3 Million
Q2 2022 Aug 09, 2022	BUY	$25.6 - $45.23 $315,468 - $557,369	12,323 Added 5.73%	227,297 $9.11 Million
Q1 2022 May 05, 2022	BUY	$33.33 - $44.6 $366,630 - $490,600	11,000 Added 5.39%	214,974 $8.02 Million
Q4 2021 Feb 02, 2022	BUY	$35.36 - $41.86 $983,644 - $1.16 Million	27,818 Added 15.79%	203,974 $8.12 Million
Q3 2021 Oct 26, 2021	BUY	$37.01 - $44.74 $579,983 - $701,120	15,671 Added 9.76%	176,156 $6.56 Million
Q2 2021 Jul 27, 2021	BUY	$37.95 - $49.37 $155,481 - $202,268	4,097 Added 2.62%	160,485 $6.78 Million
Q1 2021 Apr 27, 2021	BUY	$46.8 - $68.92 $293,997 - $432,955	6,282 Added 4.19%	156,388 $7.41 Million
Q4 2020 Jan 29, 2021	SELL	$47.96 - $67.64 $678,250 - $956,564	-14,142 Reduced 8.61%	150,106 $9.16 Million
Q3 2020 Nov 10, 2020	SELL	$45.41 - $57.07 $888,537 - $1.12 Million	-19,567 Reduced 10.64%	164,248 $7.68 Million
Q2 2020 Aug 07, 2020	SELL	$42.56 - $54.98 $283,917 - $366,771	-6,671 Reduced 3.5%	183,815 $9.33 Million
Q1 2020 Apr 28, 2020	SELL	$32.37 - $59.36 $1.14 Million - $2.1 Million	-35,324 Reduced 15.64%	190,486 $8.5 Million
Q4 2019 Feb 12, 2020	SELL	$32.22 - $50.07 $1.35 Million - $2.09 Million	-41,813 Reduced 15.62%	225,810 $10.8 Million
Q3 2019 Oct 29, 2019	SELL	$33.82 - $48.17 $3,551 - $5,057	-105 Reduced 0.04%	267,623 $9.05 Million
Q2 2019 Jul 30, 2019	BUY	$35.42 - $45.0 $4.79 Million - $6.09 Million	135,289 Added 102.15%	267,728 $12 Million
Q4 2018 Jan 25, 2019	SELL	$29.83 - $46.51 $40,479 - $63,114	-1,357 Reduced 1.01%	132,439 $4.55 Million
Q3 2018 Oct 24, 2018	SELL	$33.9 - $47.77 $512,025 - $721,518	-15,104 Reduced 10.14%	133,796 $6.29 Million
Q2 2018 Jul 09, 2018	SELL	$25.7 - $47.88 $229,629 - $427,807	-8,935 Reduced 5.66%	148,900 $5.02 Million
Q1 2018 May 11, 2018	SELL	$17.46 - $32.59 $2.43 Million - $4.53 Million	-138,969 Reduced 46.82%	157,835 $4.27 Million
Q1 2018 Apr 19, 2018	BUY	$17.46 - $32.59 $2.29 Million - $4.27 Million	131,146 Added 79.17%	296,804 $8.03 Million
Q4 2017 Jan 24, 2018	SELL	$15.14 - $20.89 $111,839 - $154,314	-7,387 Reduced 4.27%	165,658 $2.76 Million
Q3 2017 Oct 17, 2017	BUY	$16.81 - $21.61 $2.91 Million - $3.74 Million	173,045	173,045 $3.46 Million

Others Institutions Holding PTCT

# of Institutions

223

Shares Held

78.1M

Call Options Held

144K

Put Options Held

58.7K

Vanguard Group Inc Valley Forge, PA

9.13M
Shares

$358 Million
0.01% of portfolio
Wellington Management Group LLP Boston, MA

7.89M
Shares

$310 Million
0.05% of portfolio
Black Rock Inc. New York, NY

7.77M
Shares

$305 Million
0.01% of portfolio
Rtw Investments, LP New York, NY

7.39M
Shares

$290 Million
4.37% of portfolio
Armistice Capital, LLC New York, NY

7.23M
Shares

$284 Million
4.46% of portfolio

View Full List

About PTC THERAPEUTICS, INC.

Ticker PTCT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,541,000
Market Cap $2.81B
Description
PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. Its portfolio pipeline includes commercial products and product candidates in various stages of development, including clinical, pre-clinical and research and discovery stages, focuses on...

More about PTCT

Track Ken Fisher's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fisher Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fisher Asset Management, LLC and Ken Fisher with notifications on news.

Account